Atrial fibrillation can cause palpitations, which are an awareness of the heart beating rapidly, irregularly, forcefully or unusually. People may describe fluttering, racing, pounding or an uneven heartbeat in the chest. The characteristic ventricular rhythm in AF is often irregularly irregular because impulses reach the ventricles through the atrioventricular node at variable intervals. Some people notice the irregularity themselves, while others discover it when checking their pulse or during a medical examination.
Palpitations can be intermittent in paroxysmal AF and persistent in sustained AF. Importantly, many people with AF have no noticeable symptoms at all. Asymptomatic AF may be detected incidentally on an ECG, during blood-pressure monitoring, by a wearable device or when a clinician identifies an irregular pulse. Lack of symptoms therefore does not mean that AF lacks clinical significance.
Breathlessness and reduced exercise tolerance are common symptoms because AF can impair cardiac efficiency. Rapid ventricular rates shorten diastolic filling time, while loss of coordinated atrial contraction removes the atrial contribution to ventricular filling. These effects can be particularly important in people with stiff ventricles, heart failure or other structural heart disease. A person may become breathless when walking, climbing stairs or performing activities that previously caused no difficulty. Some people notice only reduced stamina or unusual fatigue.
The severity can fluctuate because ventricular rate, duration of AF and underlying cardiac reserve vary. Breathlessness is not specific to AF and can result from lung disease, anaemia, heart failure and many other conditions, so an irregular pulse or ECG is needed to establish the rhythm when AF is suspected.
Fatigue and weakness can result from the irregular and sometimes rapid ventricular rate and from reduced effective cardiac output. Because ventricular filling varies from beat to beat, stroke volume can also vary, producing inconsistent blood flow to tissues. Persistent rapid AF increases myocardial workload and can eventually contribute to tachycardia-induced cardiomyopathy in susceptible individuals. A person may therefore experience reduced concentration, poor stamina or a general sense that ordinary physical activity has become more difficult.
Fatigue can be especially difficult to recognise as an arrhythmia symptom because it is common in sleep disorders, infections, anaemia, endocrine disease and psychological conditions. A new or unexplained decline in exercise capacity becomes more informative when it occurs alongside palpitations, an irregular pulse or episodic breathlessness.
Dizziness, light-headedness and near-fainting can occur when AF causes a rapid ventricular rate or when the resulting cardiac output is insufficient for the body's immediate needs. In some people, particularly those with conduction disease or medication effects, the ventricular response can instead become unusually slow. The haemodynamic impact depends on ventricular function, blood pressure, rate, rhythm and other cardiovascular conditions.
True syncope is less typical of uncomplicated AF than palpitations or breathlessness, but fainting can occur when AF is associated with very rapid rates, significant pauses, other arrhythmias or structural heart disease. Syncope in a person with suspected arrhythmia warrants careful assessment because it can indicate a rhythm capable of causing transient cerebral hypoperfusion or a more dangerous associated electrical disorder.
Chest discomfort can occur during AF, particularly when a rapid ventricular rate increases myocardial oxygen demand or when underlying coronary disease is present. Some people experience pressure, tightness or discomfort rather than a sharp pain. AF itself does not automatically mean that chest pain is caused by the arrhythmia, and acute coronary syndrome must be considered when symptoms are suggestive. Breathlessness, sweating, nausea or severe chest pressure accompanying a rapid or irregular heartbeat can represent a medical emergency. AF can also worsen pre-existing heart failure, producing increased breathlessness, oedema and reduced exercise tolerance. The relationship can work in both directions: heart failure can predispose to AF, and uncontrolled AF can aggravate cardiac dysfunction.
Some symptoms are related to the consequences of AF rather than the rhythm sensation itself. Reduced atrial contraction and blood stasis can promote thrombus formation, especially in the left atrial appendage. If a clot embolises to the brain, it can cause an ischaemic stroke, whose symptoms may include sudden facial weakness, arm weakness, speech difficulty, visual disturbance, confusion or other neurological deficits.
Stroke is therefore a major clinical consequence of AF even though the person may never have felt the arrhythmia. Transient ischaemic attacks can produce temporary neurological symptoms. The absence of palpitations cannot be used to assume that stroke risk is absent. Anticoagulation decisions are based primarily on thromboembolic risk factors and clinical assessment rather than on how strongly a person perceives their heartbeat.
AF symptoms can vary according to whether the condition is paroxysmal, persistent or longstanding. A person with paroxysmal AF may have abrupt episodes of racing or irregular heartbeat that last minutes or hours and then stop, while someone with persistent AF may have continuous symptoms or become accustomed to the abnormal rhythm and notice little. Triggers such as alcohol, illness, exertion, sleep disruption or stimulants can coincide with episodes in some individuals. Conversely, AF can occur without an identifiable trigger. Wearable devices can sometimes identify an irregular rhythm during asymptomatic episodes, but consumer alerts are not definitive diagnoses. Clinical ECG confirmation is important because premature beats and other rhythms can produce similar sensations and because management depends on accurately identifying AF.
The symptoms of atrial fibrillation range from no symptoms at all to palpitations, breathlessness, fatigue, reduced exercise tolerance, dizziness and chest discomfort. More severe consequences can include worsening heart failure or thromboembolic stroke. The pattern of symptoms does not reliably indicate the severity of the arrhythmia or its stroke risk, which is why objective rhythm documentation and cardiovascular risk assessment are important.
A new rapid or irregular heartbeat accompanied by severe chest pain, severe breathlessness, fainting or neurological symptoms requires urgent medical attention. Sudden facial drooping, arm weakness or speech disturbance is an emergency because it may indicate stroke. For suspected AF without emergency symptoms, clinicians can confirm the rhythm with ECG or longer-term monitoring and then assess rate, symptoms, underlying causes and stroke risk to determine appropriate management.
